Status:
COMPLETED
an Istitution Experience on Parosteal OsTeosarcoma
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Parosteal Osteosarcoma
Eligibility:
All Genders
Brief Summary
single institution cases series review of histological and clinical data
Detailed Description
Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.
Eligibility Criteria
Inclusion
- Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018
- Diagnosis of parosteal osteosarcoma
- Written informed consent prior to any study-specific analysis and/or data collection
Exclusion
- • Patients with histological diagnosis different from parosteal osteosarcoma
Key Trial Info
Start Date :
November 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03768076
Start Date
November 30 2018
End Date
February 28 2019
Last Update
August 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto ortopedico Rizzoli
Bologna, Italy, 40136